ANK3 and Familial prostate cancer: While it has been shown that downregulation of ANK3 is associated with poor prognosis in multiple cancers such as prostate, ovarian, lung and breast27, a recent study also described that increased ANK3 contributes to prostate cancer progression, implying that both up and down regulation of this gene can be important at different clinical stages28.